HealthIT.com
Menu

Rapid CTA

RapidAI · Emergency + hospital · Cloud + on-prem

Imaging & Diagnostic AI

Stroke and vascular imaging AI (CTP/CTA analysis) with the largest published stroke-imaging evidence base and hospital network deployment for stroke-system coordination.

Evidence at a glance

Freshness, source-checked counts, confidence and gate results below reflect the frozen evidence snapshot through . A later editorial review does not update these results.

Stated intended users
Stroke centers, health-system stroke networks
Documentary gate at snapshot
Failed
Scenario match
Matches this scenario — FDA-cleared imaging AI platforms
Comparability
Not yet comparable in this scenario
Decision readiness at snapshot
HISTORICAL — Research only
Documented evidence at snapshot
0 of 2 evidence claims source-checked · confidence Low
Critical unknowns
No critical documentary gaps identified
Latest checked-source retrieval in snapshot
not yet measured

Expand each claim to inspect its source, dates and recorded verification status.

independent reportMultiple FDA clearances for stroke imaging listed on FDA AI device list; the most-cited CTP platform in stroke trials.2026-03-20

Exact claim. Multiple FDA clearances for stroke imaging listed on FDA AI device list; the most-cited CTP platform in stroke trials.

Source
fda.gov
Type
independent report
Published
2026-03-20
Retrieved
2026-08-27
Verification
unverified
Confidence
not stated
Reviewer
healthit-gate-v1
Claim version
v1
Supports
trust_governance
Score contribution
Feeds trust governance

Independent source. Methodology and sample vary by report; read the underlying method.

Open fda.gov
independent reportIn 477 consecutive stroke-suspected CTAs, the RAPID CTA automated large vessel occlusion detection algorithm achieved sensitivity of 0.94 an…2019-10-01

Exact claim. In 477 consecutive stroke-suspected CTAs, the RAPID CTA automated large vessel occlusion detection algorithm achieved sensitivity of 0.94 and negative predictive value of 0.98 with a median processing time of 158 seconds (IQR 150-167) (Stroke, 2019).

Source
ahajournals.org
Type
independent report
Published
2019-10-01
Retrieved
2026-08-27
Verification
unverified
Confidence
not stated
Reviewer
healthit-gate-v1
Claim version
v1
Supports
evidence_strength
Score contribution
Feeds evidence strength

Independent source. Methodology and sample vary by report; read the underlying method.

Open ahajournals.org

Verified provider experience is not yet publishable. Fewer than five independent provider organizations have contributed eligible reviews. Reviewer mode is off. Experience never changes documentary scoring, freshness, or rank.

Buyer lenses — evidence-backed bands at snapshot (not a 0–100 rank)
Clinical · Thinner · missing deployment_traction, economic_value
Operations · Thinner · missing deployment_traction, economic_value
Security & Privacy · Moderate · missing deployment_traction
IT & Interop · Moderate · missing deployment_traction
Finance & Procurement · Moderate · missing deployment_traction, economic_value
Strategic · Moderate · missing deployment_traction
Deployment, integration, data handling at snapshot
Integration maturity
live — Listed on an EHR marketplace/partner program — live distribution.
EHR path
DICOM/PACS, stroke mobile coordination apps
FHIR / API
UNKNOWN
Why unknown

Why. No reliable source on file. The platform does not infer values from weak sources.

What would close it. A primary source or independent verification.

SSO
UNKNOWN
Why unknown

Why. Single-sign-on support is not documented in vendor or marketplace materials on file.

What would close it. Vendor security documentation or marketplace listing mentioning SSO/SAML/OIDC.

PHI / BAA
BAA; imaging data · BAA available
Security attestations
HIPAA, ISO 13485
FDA status
CLEARED
Pricing
Not publicly listed
Technical provenance

snap_36bba25c577cbb44 · Evidence cutoff: 2026-08-27T04:05Z · Snapshot generated: 2026-10-21T19:39Z · build ffbf5c3

Forecast calibration is not in the public snapshot — shown as UNKNOWN rather than read from SQLite.

Known limitations
  • Deployment traction is UNKNOWN.
    Why unknown

    Why. No reliable source on file. The platform does not infer values from weak sources.

    What would close it. A primary source or independent verification.

  • Economic value evidence is UNKNOWN.
    Why unknown

    Why. No independently verifiable ROI claim (peer-reviewed, audited case, or independent benchmark) is on file.

    What would close it. An audited implementation report or peer-reviewed study with payback/throughput numbers.

Know something we have wrong about Rapid CTA?

Checking feedback availability…

Open to everyone — no account needed. This is a non-PHI service: never include patient identifiers.

We cannot action an evidence claim without something to check.

Your message is privately delivered to the editorial team. How we handle your information.